16:09 EDT PTC Therapeutics backs FY24 revenue view $600M-$680B, consensus $606.63M
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PTCT:
- PTC Therapeutics submits MAA for sepiapterin in PKU to EMA
- Cantor Fitzgerald biotech analyst holds an analyst/industry conference call
- PTC Therapeutics provides regulatory updates
- PTC Therapeutics price target raised to $28 from $22 at RBC Capital
- PTC Therapeutics price target lowered to $30 from $32 at TD Cowen
